We believe this is an effective and appropriate way to conduct this study.

Certainly there has been confusion among doctors and patients but this will be clarified by new labeling for all pain relievers that is being negotiated with the FDA at the current time.

If you haven't heard about it, we haven't announced anything.

I was really surprised by it. This case is about a 12-year-old boy. This is a child. We need to remember that.

The EU has carefully analyzed the (first WTO) arbitration award, revised its proposal accordingly, and initiated consultations with our Latin American and ACP partners on this basis,

to be very offensive on finding an end-date. It will not be the EU that is lagging.